These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16601641)

  • 21. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychopharmacology of ADHD in adolescents.
    Greydanus DE; Sloane MA; Rappley MD
    Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 26. Methylphenidate-induced obsessive-compulsiveness.
    Kouris S
    J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):135. PubMed ID: 9473905
    [No Abstract]   [Full Text] [Related]  

  • 27. ADHD, methylphenidate and driving: does some legislation endanger public health?
    Verster JC; Cox DJ
    J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623
    [No Abstract]   [Full Text] [Related]  

  • 28. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C
    Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
    [No Abstract]   [Full Text] [Related]  

  • 29. Methylphenidate euphoria.
    Corrigall R; Ford T
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
    [No Abstract]   [Full Text] [Related]  

  • 30. Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
    Kalb C
    Newsweek; 2000 Mar; 135(10):53. PubMed ID: 10847892
    [No Abstract]   [Full Text] [Related]  

  • 31. Medication-induced seizures.
    Feeney DJ; Klykylo WM
    J Am Acad Child Adolesc Psychiatry; 1997 Aug; 36(8):1018-9. PubMed ID: 9256580
    [No Abstract]   [Full Text] [Related]  

  • 32. Stimulant use and trichotillomania.
    Martin A; Scahill L; Vitulano L; King RA
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):349-50. PubMed ID: 9549952
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
    Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F
    Encephale; 1997; 23(4):251-6. PubMed ID: 9417389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Explosive outbursts associated with methylphenidate.
    Adrian N
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):618-9. PubMed ID: 11392335
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacologic treatment of attention deficit hyperactivity disorder.
    Greenhill LL
    Psychiatr Clin North Am; 1992 Mar; 15(1):1-27. PubMed ID: 1347936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial.
    Işeri E; Kiliç BG; Senol S; Karabacak NI
    Methods Find Exp Clin Pharmacol; 2007; 29(1):47-52. PubMed ID: 17344944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
    Yoo HK; Park S; Wang HR; Lee JS; Kim K; Paik KW; Yum MS; Ko TS
    Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
    Ghanizadeh A
    J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458
    [No Abstract]   [Full Text] [Related]  

  • 39. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 40. BPD and ADHD.
    Lombardo GT
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):719-20. PubMed ID: 9183120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.